BooksDirect

Description - COVID-19: From Bench to Bedside by Debmalya Barh

The COVID-19 pandemic has affected the entire world in an unprecedented way, and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic. Experts of the respective domains provide details on anti-SARS-CoV-2 drug strategies, including repurposing drugs used for other indications and the development of novel drugs looking at different approaches to target virus entry and replication. COVID-19 vaccine development based on inactivated and attenuated live virus, protein subunit and peptide-based vaccines and utilization of vaccine candidates based on viral vectors, DNA and RNA are presented for both preclinical studies and clinical trials.

Key Features

  • Explains the background of the COVID-19 pandemic, the current progress in the development of treatments and prevention of COVID-19 including future aspects of dealing with the pandemic
  • Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management

Buy COVID-19: From Bench to Bedside by Debmalya Barh from Australia's Online Independent Bookstore, BooksDirect.

Other Editions - COVID-19: From Bench to Bedside by Debmalya Barh

A Preview for this title is currently not available.
COVID-19: From Bench to Bedside
Paperback , Mar '22
RRP: $154.00 $152.46
OMICS
Hardback , Nov '11
RRP: $273.00 $267.54
OMICS Applications in Crop Science
Hardback , Dec '13
RRP: $546.00 $491.40
Cancer Biomarkers
Hardback , Jan '14
RRP: $546.00 $491.40